We follow industry news and trends so you can stay ahead of the game. Subscribe to receive emails regarding policies and findings that impact you and your business.

Already a subscriber and want to update your preferences? Click here.

BACK TO NEWS

MEDIA MENTIONS

DEC 19 2024

FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage - USA Today

Dae Y. Lee, Pharm.D., Esq., CPBS, shareholder in the firm's FDA section, was featured in a USA Today article entitled "FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage ."